Daré Bioscience, Inc. (DARE): Price and Financial Metrics

Daré Bioscience, Inc. (DARE): $3.18

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add DARE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#163 of 332

in industry

DARE Price/Volume Stats

Current price $3.18 52-week high $7.56
Prev. close $3.18 52-week low $3.05
Day low $3.18 Volume 20,800
Day high $3.20 Avg. volume 47,286
50-day MA $3.55 Dividend yield N/A
200-day MA $4.29 Market Cap 27.67M

DARE Stock Price Chart Interactive Chart >


Daré Bioscience, Inc. (DARE) Company Bio


Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women's health in the United States. The company intends to develop therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single application that completed Phase 3 clinical trials; Ovaprene, a hormone-free, monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone replacement therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214 injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is based in San Diego, California.


DARE Latest News Stream


Event/Time News Detail
Loading, please wait...

DARE Latest Social Stream


Loading social stream, please wait...

View Full DARE Social Stream

DARE Price Returns

1-mo -14.29%
3-mo -10.42%
6-mo -39.22%
1-year -20.16%
3-year -83.64%
5-year -67.66%
YTD -14.24%
2023 -62.77%
2022 -58.50%
2021 49.25%
2020 63.41%
2019 15.49%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!